baber/WOPTO huggingface dataset:
Patent PT-1773361-E (PT)
Title: Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
Inventor: MOGNA GIOVANNI
IPC: A61K35/745
Filed: 2005-10-05
Abstract: The object of the present invention is a probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the contemporaneous improvement of the intestinal functionality, which can be compromised by therapeutic treatments adopted for re-solving said pathological conditions. Besides that, aim of this invention is a probiotic bacteria-based composition comprising moreover a suitable quantity of at least a substance or nourishment having prebiotic properties and eventually, of suitable pharmacologically active substances.
Patent PT-2077811-E (PT)
Title: Clay-based hemostatic agents and devices for the delivery thereof
Inventor: HUEY RAYMOND
IPC: A61F13/00
Filed: 2007-07-20
Abstract: A device capable of providing a hemostatic effect on a bleeding wound
Patent PT-2230670-E (PT)
Title: Medium voltage cable
Inventor: SVENSSON PANCH
IPC: H01B3/44
Filed: 2009-03-16
Abstract: A cable for transmitting electrical power at a voltage between 5 and 49 kV comprising a conductive cable core (12) and an insulation layer (16) for insulating the cable core (12), the insulation layer (16) comprising from 50 to 90% of crosslinked polyethylene, and from 10 to 50% of ethylene-alkyl acrylate and/or ethylene vinyl acetate. The insulation layer is provided with a strippable outer semiconductive screen (18), which comprises from 30 to 70% by weight of a composition (A) of at least one copolymer selected from the group consisting of ethylene-alkyl acrylate carbon monoxides. The combination of materials in the insulator (16) and the semiconductive screen (18) provides for high water-tree resistance of the insulator (16) and strippability of the semiconductive screen (18).
Patent PT-2306988-E (PT)
Title: Pharmaceutical formulation for treating the upper digestive tract
Inventor: WILHELM RUDOLF
IPC: A61K9/46
Filed: 2009-07-02
Abstract: Effervescent tablet (I) comprises budesonide. ACTIVITY : Antiinflammatory; Gastrointestinal-Gen.; Immunosuppressive. MECHANISM OF ACTION : None given.
Patent PT-665221-E (PT)
Inventor: MIKAMI TETSUHIRO
IPC: C07C401/00
Filed: 1993-10-18
Abstract: A highly crystalline vitamin D derivative represented by general formula (I), and a process for producing a highly pure 22-oxavitamin D derivative by hydrolyzing the above compound, wherein R1 represents optionally hydroxylated linear or branched C4-C9 alkyl, and R2 and R3 may be the same or different from each other and each represents acyl. <CHEM>
Patent PT-640608-E (PT)
Inventor: LUDESCHER JOHANNES
IPC: C07D501/00
Filed: 1994-07-29
Abstract: Novel amidine salts of 7-Amino-3-hydroxymethyl-3-cephem-4-carboxylic acid (= HACA), particular guanidine and diaza-bicyclo-alkylene salts, are useful as intermediates in the synthesis of cephalosporins.
Patent PT-702902-E (PT)
Inventor: CAMPBELL LYDIA
IPC: A23L27/60
Filed: 1994-09-24
Abstract: The invention concerns a heat-stable oil-in-water emulsion containing from 5 to 75% fat, from 0.1 to 10% vinegar, from 0.1 to 5% DATEM and from 0.1 to 10% protein salt and/or sugar, aroma and water and having a pH of from 3 to 8.
Patent PT-759929-E (PT)
Inventor: BAKSHI RAMAN K
IPC: B01J31/16
Filed: 1995-05-15
Abstract: The instant invention involves a process for oxidizing compounds containing an allylic group, i.e. those containing an allylic hydrogen or allylic alcohol group, to the corresponding enones, using a ruthenium-based catalyst in the presence of a hydroperoxide. Particularly, DELTA-5-steroidal alkenes can be oxidized to the corresponding DELTA-5-7-keto alkenes.
Patent PT-774004-E (PT)
Title: Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme
Inventor: DIU ANITA
IPC: C12N5/10
Filed: 1995-08-01
Abstract: DNA sequences coding for human polypeptides with protease activity and capable of inducing apoptosis, related to the interleukin-1beta converting enzyme are disclosed.
Patent PT-843680-E (PT)
Inventor: COOK MICHAEL ALLEN
IPC: C07D503/18
Filed: 1996-07-30
Abstract: A process for preparation of potassium clavulanate by the direct precipitation of clavulanic acid as the potassium salt by providing a solution of clavulanic acid in an organic solvent and mixing a potassium salt with this solution, with between 0.1 % v:v and 7.5 % v:v of water present in the region where the clavulanic acid and potassium salt contact, then isolating the so-formed potassium clavulanate.
Patent PT-915910-E (PT)
Inventor: EIKE HOFFMANN
IPC: A61P3/10
Filed: 1997-06-05
Abstract: The invention concerns exendin analogues which can be used in the treatment of diabetes mellitus. The invention also concerns processes for preparing these substances and medicaments containing them. The exendin analogues are derived from SEQ ID:1(I) or SEQ ID:2(II).
Patent PT-917588-E (PT)
Inventor: BOOTEN KARL
IPC: A23L33/21
Filed: 1997-07-25
Abstract: A method for preparing a polydispersed saccharide composition in which a fructan-containing material is dissolved in water prior to partial enzymatic treatment of the fructans.
Patent PT-920495-E (PT)
Title: Transgenic animal model for alzheimer disease
Inventor: SOMMER BERND
IPC: C12N5/10
Filed: 1997-07-23
Abstract: The invention provides transgenic non-human animals which exhibit both APP and tau-linked features, e.g. histological features, of AD pathology, and preferably also behavioural changes characteristic of AD. Suitably the transgenic non-human animals express a human APP comprising the Swedish mutation or the Swedish mutation in combination with one or more additional mutations, in particular the London mutation. It appears that the level at which the transgene is expressed in the transgenic animal, e.g. the level of transgene mRNA, is an important factor for obtaining AD pathology in the animal. Transgenic mice expressing said mutated human APP under control of Thy-1 promoter element have been found to develop a pathological phenotype which goes beyond that previously described by Games et al. [Nature 373, 523-527, (1995)], by combining APP and tau-linked features of the AD pathology. Moreover, the mice have been found to present behavioural changes characteristic of AD, which has also never been reported before with transgenic animals.
Patent PT-995463-E (PT)
Inventor: WOLF A KAFKA PROF
IPC: A61N2/02
Filed: 1998-10-21
Abstract: The device has a coil (2) to generate a pulsed electromagnetic field and a pulse generator (1) to control the coil. The pulsed electromagnetic field comprises a number of single pulses of frequencies between 1 Hz and 1 kHz. The amplitude of each single pulse agrees with a given equation. The amplitude, y, of each single pulse is of the function: y = (kxaesin (xb))/c + d, where x is the pulse time, a is a parameter to adjust the amplitude of each pulse, b is the number of the overlaid pulse, c is a factor to adjust the amplitude, d is an offset value, and k is a factor to adjust the amplitude of the overlaid pulse.
Patent PT-928799-E (PT)
Inventor: SONNTAG MICHAEL
IPC: C09D175/04
Filed: 1998-12-24
Abstract: The use of 4-isocyanatomethyl-1,8-octanediisocyanate (I) for the production of aqueous polyurethane lacquers and coatings is claimed.
Patent PT-1023106-E (PT)
Title: Device for magnetic field therapy
Inventor: MUNTERMANN AXEL
IPC: A61N2/00
Filed: 1998-10-16
Abstract: The arrangement has at least one device for generating a magnetic field with static and alternating components at the position of the tissue being treated. The alternating field has a defined cell biorhythm frequency and is essentially monochromatic. The field is modulated with a frequency defined by Bq/2pi m, where B is the static magnetic flux density, q is the charge and m is the mass of the predefined ion. Alternatively, the field may have a predefined organ biorhythm frequency.
Patent PT-1038094-E (PT)
Inventor: HARAZIM WOLFGANG
IPC: F02C1/10
Filed: 1998-12-09
Abstract: The aim of the invention is to further improve the closed cycle for generating electric power in such a way that efficiency is enhanced and general pressure and temperature requirements regarding the working fluid used are substantially reduced. The invention also seeks to provide an improved technical solution that meets the requirements of continuos operation at rated output despite fluctuations in load requirements. This is achieved through a multistep steam power operating method for generating electric power in a cycle by using an additional gaseous energy carrier to increase the pressure, the temperature and the volume of the working fluid in the cycle and by recirculating the working fluid in the cycle in such a way that continuously overheated steam is used as a working fluid. The invention can be used in the generation of electric power in a cycle.
Patent PT-990866-E (PT)
Inventor: CHRIST MICHAEL
IPC: F26B13/10
Filed: 1999-08-27
Abstract: A hot gas drying system for continuous material feeds, e.g. for textile processing, has the horizontal material feed (WB) inside a control jet (6) to spread the hot gasses even over the material. The gasses are supplied via a blower (5) whose inlet duct (7a) extends into a filter cage (11) around the burner. The extension of the inlet duct is profiled (8) to generate a venturi effect and is spaced away from the filter cage, with the end of the gas burner inside the duct. This creates a ring space for efficient mixing with the recirculated gasses.
Patent PT-1058117-E (PT)
Inventor: SCHULE ROLAND
IPC: A61P5/30
Filed: 1999-05-21
Abstract: Extracorporeal use of the SLIM3 protein for binding to at least one of the nuclear proteins androgen receptor (AR) and estrogen beta receptor (ERb). All proteins may be in modified forms with deletion, substitution or insertion of up to 10 amino acids, provided that the function of the parent protein is retained. Independent claims are also included for the following: (1) use of amino acid sequences of SLIM3, encoded by a cDNA, for binding amino acids sequences of AR and ERb, also encoded by cDNAs, where optionally one or more of the cDNAs are modified but have at least 85% homology to sequences that encode the native proteins and encode a protein with the same function as the native protein; and (2) extracorporeal method for identifying ligands that modulate interaction between SLIM3 and AR or ERb.
Patent PT-1072734-E (PT)
Title: Adhesive spreader
Inventor: SOUTHBY ROYDON CHARLES
IPC: E04F21/20
Filed: 1999-07-30
Abstract: A spreader for use in spreading a bed of predetermined thickness of adhesive material on a prepared floor surface prior to the laying of tiles. The spreader comprises a rectangular planar portion (2) having a serrated lower longitudinal edge (4) and flanges (6 and 8) extending substantially at right angles from the transverse edges of the rectangular planar portion (2). The flanges provide a barrier allowing a mass of adhesive to lie in front of the serrated edge (4) and between the flanges (6 and 8) as the spreader is drawn over the surface of the surface to be tiled. As the spreader is drawn over the surface the adhesive flows under the serrated edge thereby providing an even application of adhesive across the full width of the spreader. A height adjuster comprising an adjustable gauge (28) is provided as is a handle (10) or elongate handle (50) for convenient use by the tiler.  <IMAGE>
Patent PT-1077718-E (PT)
Inventor: BOHANON MICHAEL JOHN
IPC: C07D413/10
Filed: 1999-05-13
Abstract: The present invention provides methods and compositions for enhancing the effectiveness of oxazolidinone antibacterial agents against gram-negative organisms infection by using an arginine derivative.
Patent PT-1084294-E (PT)
Inventor: WILSON ROBERT G
IPC: D21F1/10
Filed: 1999-05-19
Abstract: A forming fabric has machine direction yarns and cross machine direction yarns interwoven in a repeating pattern of multiple repeating units. The repeating units of the pattern comprise: paper side cross-machine direction yarns forming the paper side of the fabric; machine side cross-machine direction yarns forming the machine side of the fabric; and machine direction yarns interwoven with both the paper side cross machine direction yarns and the machine side cross machine direction yarns. The machine direction yarns comprise first and second sets of machine direction yarns arranged in an alternating pattern. Each of the machine direction yarns of the first and second sets passes above four paper side cross machine direction yarns to form paper side knuckles separated from one another by at least two paper side cross machine direction yarns. Each of the machine direction yarns of the first set passes below four machine side cross machine direction yarns to form first, second, third and fourth machine side knuckles, and each of said machine direction yarns of said second set passes below three machine side cross machine direction yarns to form fifth, sixth and seventh paper side knuckles. In this configuration, the fabric retains a desired "zig-zag" configuration on the machine side, but is less prone to twinning.
Patent PT-1114206-E (PT)
Inventor: SONNTAG BIRGIT
IPC: C25D3/56
Filed: 1999-07-26
Abstract: An aqueous alkaline cyanide-free bath for the galvanic deposition of zinc or zinc alloy coatings on substrate surfaces is described, which contains in addition to a source of zinc ions and optionally a source of further metal ions, also hydroxide ions and a polymer of the general formula A that is soluble in the bathas well as optionally conventional additives. The bath may furthermore contain a quaternary derivative of a pyridine-3-carboxylic acid of the formula B and/or a quaternary derivative of a pyridine-3-carboxylic acid of the formula CA process for the galvanic deposition of zinc coatings and zinc alloy coatings using the aforedescribed bath is also described.By using the baths according to the invention it is possible to produce coatings that exhibit a uniform layer thickness combined with a high gloss, and which do not exhibit any tendency to exfoliate.
Patent PT-1115693-E (PT)
Title: Substituted polycyclic aryl and heteroaryl $i(tertiary)-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
Inventor: SIKORSKI JAMES A
IPC: C07C291/04
Filed: 1999-09-23
Abstract: The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Novel high yield, stereoselective processes for the preparation of the chiral substituted alkanol compounds from chiral and achiral intermediates are described.
Patent IE-32611-L (IE)
Title: Identity cards
IPC: B42D25/00
Filed: 1969-01-03
Abstract: 1,249,900. Preventing fraud. ANDREMAWERKE G.m.b.H. 31 Dec., 1968, [5 Jan., 1968], No. 61829/68. Heading B6A. An identity card comprises a carrier 1 bearing a thin coating 2 of a material suitable for receiving writing and having its surface formed into a pattern 3 which is easily disturbed by, and thus renders apparent, writing or erasive of writing thereon. The carrier 1 may be formed of hard PVC having a glossy surface. The coating 2 is of softer plastics material which may be highly pigmented so that it has a matt or rough surface. The pattern 3 may comprise .perforations which may be letters representing repetitions of a monogram, and pass through the coating 2 as in Fig. 4, or may comprise recesses forming an intaglio pattern (Fig. 6, not shown). The carrier 1 may be of a different color than the coating 2 so that the pattern, when formed as perforations, stands out. The identity card may be punched from a sheet (4), Fig. 5, not shown, on which a plurality of identity cards are printed, the coatings (5) being applied during the printing operation.
[GB1249900A]
Patent IE-800046-L (IE)
Title: Pleuromutilins.
IPC: C07D277/16
Filed: 1980-01-10
Abstract: Novel pleuromutilin derivatives of formula I, <IMAGE> I in which R1 is ethyl or vinyl, m is 0 or 1, and R2 is a heterocyclic radical, in which a 5- or 6-membered, unsaturated or saturated heterocyclic ring containing one or more hetero atoms selected from oxygen, sulphur and nitrogen, is attached to the -S(CH2)m-group, provided that when m is 0, R2 is other than pyridyl, their production and use as antimicrobial agents are described.
[US4428953A]
Patent IE-44484-L (IE)
Title: Temporary planting device
IPC: A01G9/10
Filed: 1977-03-03
Abstract: 1536796 Plant substrate bodies KEYES FIBRE CO 25 Feb 1977 [15 March 1976] 08005/77 Heading A1E A planting substrate assembly comprises a strip 51 of ridge-shaped planting "pods" interdigitated with the "pods" of a strip 52 to form a nested pair of strips, a plurality of such pairs of strips being assembled into a block 10 having its sides encircled by a wrapper 88. The strips are separated by growth barrier films 71, 72. Each strip is integrally moulded, chiefly of peat, and each "pod" thereof may be formed at one end with a seed or plant well 40 to receive a single seed or plantlet. The seeds are germinated, and initial growth takes place, in the assembled block. For planting out an entire strip may be inserted into a groove in the ground, or each "pod" can be detached and individually planted.
[GB1536796A]
Patent IE-39201-L (IE)
Title: Method of treating swine dysentery
IPC: A23K1/18
Filed: 1974-04-04
Abstract: 1430411 Treatment of swine dysentry MAY & BAKER LTD 3 April 1974 [5 April 1973] 16327/73 Heading A5B Swine dysentry is combatted by administering to pigs a compound of general formula: wherein R and R<1> may be the same or different and are each H or C1-4 alkyl, or a non-toxic salt thereof. Administration may be oral or parenteral, the compositions used being in conventional forms containing conventional carriers and excipients, Also claimed are concentrates for addition to feedstuff or drinking water comprising active material and a surface active wetting, dispersing or emulsifying agent and, optionally, a carrier.
[GB1430411A]
Patent IE-810776-L (IE)
Title: Liquid dispensing machine
IPC: G01F23/292
Filed: 1981-06-06
Abstract: A machine for filling a drinking vessel to a desired level, irrespective of the lateral dimensions of the vessel includes means for supporting the vessel 29 below a delivery pipe 18 for the liquid 33, and a reflex sensor 19 comprising means 30 for directing a beam of radiation into the open mouth of the vessel and a detector 31 to detect the intensity of the radiation reflected from the surface 32 of the liquid. When the intensity of reflected radiation detected by the detector 31 reaches a given level, corresponding to the desired level of liquid in the vessel, a control module 23 associated with the reflex sensor 19 automatically de-energises a solenoid 24 which closes a valve 21 in the delivery pipe 18 and cuts off the supply of liquid to the vessel. If the liquid has a surface with a settlable nature, such as the frothy surface of a beer, the supply of liquid is automatically resumed when the level falls, preferably after a predetermined delay to prevent excessive topping-up operations. <IMAGE>
[GB2099791A]
Patent IE-830819-L (IE)
Title: Dithiolan derivatives
IPC: C07D339/06
Filed: 1983-04-11
Abstract: N-(1-3-dithiolan-2-ylidene)-4-alkylanilines having a hydroxy, alkoxy or alkanoyloxy substituent on the alkyl group are useful as anti-inflammatory agents, as analgesic agents and as antiasthmatic agents. The compounds involved can be prepared by the reaction of an appropriate 4-alkylaniline with a methyl(1,3-dithiolan-2-ylidene)sulfonium salt or with carbon disulfide and ethylene dibromide in the presence of a base.
Patent IE-33381-L (IE)
Title: Reinforcing yarns, cords
IPC: B29C70/04
Filed: 1969-07-31
Abstract: 1275412 Tyre bead-cores DUNLOP HOLDINGS Ltd 4 Aug 1969 [3 Aug 1968] 37148/68 Heading B7C [Also in Divisions D1-D2] A method for the manufacture of a reinforcing yarn or cord comprises impregnating a bundle or bundles of brittle filaments with a liquid which can be converted into an elastic solid having a Poisson's ratio of at least 0À45 at tensile strains not greater than 5%, twisting the bundle or bundles and converting the liquid into the elastic solid, the brittle filaments being filaments which have a specific modulus of at least 200 Î 10<SP>6</SP> inches. Examples of such brittle filaments are carbon, boron and graphite. The liquid may be convertible by cooling or chemical cross-linking. The liquid may be converted into the elastic solid before or after the twisting of the bundle or bundles of filaments. In a preferred embodiment, the liquid is a resorcinolformaldehyde-latex adhesive composition. The liquid may alternatively be a solution of a polymer in an organic solvent, e.g. cis-polyisoprene in n-hexane containing dicumyl peroxide; the liquid may be a liquid polyurethane. The amount of twist inserted into the yarn or cord is such that the mean helix angle of the filaments with respect to the yarn axis or of the cord is not greater than 20 degrees. In the reinforcing yarn or cord, each filament is sheathed with the elastic solid. The yarn may be used as the bead-core for a penumatie tyre casing, several turns of yarn being embedded in rubber such that the cross-section of the assembly is approximately square or rectangular.
[GB1275412A]
Patent IE-821071-L (IE)
Title: Tubular container
IPC: B32B1/02
Filed: 1982-05-06
Abstract: The production of a tubular container is effected by rolling and lap-welding a multi-ply foil to form a cylindrical tube body (1), the arrangement of a collar (5) which partially closes this tube body (1) at the top, and the production of a head piece (4) of plastics material, which on the one hand connects the tube body (1) to the collar (5) and on the other hand forms the top closure of the tube. The collar (5) has a simple basic form before working and is brought by the working into a form in which its cut edges can be covered by plastics material flowing thereover, this shaping requiring no additional working operation, but being effected by the forces set up during the moulding process of the plastics material. Further by the shaping of the collar (5), the spacing between the collar and the tube body is reduced, thereby further improving protection against diffusion.
[US4664284A]
Patent IE-34538-L (IE)
Title: Sliding clasp fastener
IPC: A44B19/60
Filed: 1970-09-18
Abstract: This invention relates to sliding-clasp fasteners and in particular to the positioning of the end stops thereon, particularly at the opening end of the fastener. In accordance with the invention, a pair of linked or otherwise integralised end stops is formed at the location of the said opening end of the fastener and is bent around for securing to the stringers and, after being mounted in position, is separated into two individual stops. During the operation of forming and separating the stops, the fastener is in the closed condition.
[US3656223A]